- Home
- CNOBP vs BRTX Comparison
CNOBP vs BRTX Comparison
Compare CNOBP & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNOBP
- BRTX
- Stock Information
- Founded
- CNOBP N/A
- BRTX 1997
- Country
- CNOBP United States
- BRTX United States
- Employees
- CNOBP 499
- BRTX N/A
- Industry
- CNOBP Major Banks
- BRTX Managed Health Care
- Sector
- CNOBP Finance
- BRTX Health Care
- Exchange
- CNOBP Nasdaq
- BRTX Nasdaq
- Market Cap
- CNOBP N/A
- BRTX 11.3M
- IPO Year
- CNOBP N/A
- BRTX N/A
- Fundamental
- Price
- CNOBP $22.26
- BRTX $1.55
- Analyst Decision
- CNOBP
- BRTX Strong Buy
- Analyst Count
- CNOBP 0
- BRTX 1
- Target Price
- CNOBP N/A
- BRTX $18.00
- AVG Volume (30 Days)
- CNOBP N/A
- BRTX 101.3K
- Earning Date
- CNOBP N/A
- BRTX 11-12-2024
- Dividend Yield
- CNOBP N/A
- BRTX N/A
- EPS Growth
- CNOBP N/A
- BRTX N/A
- EPS
- CNOBP N/A
- BRTX N/A
- Revenue
- CNOBP N/A
- BRTX $377,000.00
- Revenue This Year
- CNOBP N/A
- BRTX $482.76
- Revenue Next Year
- CNOBP N/A
- BRTX $212.24
- P/E Ratio
- CNOBP N/A
- BRTX N/A
- Revenue Growth
- CNOBP N/A
- BRTX 189.55
- 52 Week Low
- CNOBP N/A
- BRTX $1.03
- 52 Week High
- CNOBP N/A
- BRTX $3.67
- Technical
- Relative Strength Index (RSI)
- CNOBP 57.71
- BRTX 54.98
- Support Level
- CNOBP $22.09
- BRTX $1.40
- Resistance Level
- CNOBP $22.57
- BRTX $1.60
- Average True Range (ATR)
- CNOBP 0.12
- BRTX 0.10
- MACD
- CNOBP -0.04
- BRTX 0.01
- Stochastic Oscillator
- CNOBP 35.56
- BRTX 85.29
About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
ConnectOne Bancorp Inc is a holding company. The company through its holding provides banking services including lending, depository, and related financial services to commercial, industrial and governmental customers. It is managed as one segment: a community bank. It generates revenue from net interest income.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.